Australia's EchoIQ gains most in over 2-months on deal with U.S. hospital firm Mayo Clinic

Shares of Australia's EchoIQ EIQ.AX rise as much as 17.1% to A$0.72; on track to record their biggest intraday pct gain since January 22

Stock at its highest level since March 12

Medical tech firm announces agreement with U.S hospital firm Mayo Clinic in preparation for potential FDA clearance of EchoSolv HF

EchoSolv HF is AI-based clinical decision-support software designed to help detect heart failure using echocardiography data

Adds agreement enables Mayo Clinic to resell and distribute EchoSolv HF following FDA clearance

Stock has risen 169.2% pct this year, including session moves